IC50, the inhibitor concentration that cuts a biological response in half

Drug Discovery Schema: DefinedTerm

Definition

The half-maximal inhibitory concentration, the concentration of an inhibitor that reduces a biological or biochemical response by 50%. IC50 is a standard measure of drug potency in pharmacology, with lower values indicating more potent compounds. IC50 depends on assay conditions, incubation time, and enzyme/substrate concentrations, and is related to the Ki (inhibition constant) by the Cheng-Prusoff equation.

Measurement and Interpretation

IC50 (half-maximal inhibitory concentration) is determined experimentally by measuring the response of a biological system (enzyme activity, cell viability, receptor binding) across a range of inhibitor concentrations, typically using 8-12 serial dilutions spanning several orders of magnitude. The dose-response curve is fitted using nonlinear regression to the four-parameter logistic equation (Hill equation): Response = Bottom + (Top-Bottom)/(1 + 10^((logIC50-X)×HillSlope)). A lower IC50 indicates more potent inhibition. The Hill slope reflects the degree of cooperativity: slopes greater than 1 suggest positive cooperativity, while slopes less than 1 may indicate negative cooperativity or heterogeneous binding sites. For accurate IC50 determination, the highest inhibitor concentration should achieve complete inhibition and the lowest should produce no inhibition.

Applications in Drug Discovery

IC50 is a fundamental parameter throughout the drug discovery pipeline. In primary screening, compounds are tested at a single concentration (typically 10 μM) to identify active hits. Confirmed hits undergo full dose-response IC50 determination. Counter-screens test selectivity against related targets — a selective compound should have 100-fold or greater IC50 difference between target and off-target. Cellular IC50 values are typically 10-100 times higher than biochemical IC50 values due to cell permeability and protein binding. In the therapeutic index calculation, the ratio of cytotoxic IC50 (CC50) to therapeutic IC50 indicates safety margin. For approved drugs, IC50 values relative to achievable plasma concentrations determine clinical dosing regimens.

In Practice

IC50 is widely used in drug discovery and related fields. Key applications include:

  • Research and experimental design in molecular biology laboratories
  • Clinical diagnostics and therapeutic development pipelines
  • Automated validation within VigyanLLM's 24-step primer design and analysis framework

Frequently Asked Questions

What is IC50?

IC50 is the concentration of an inhibitor that reduces a biological response by 50%, a standard drug potency measure where lower values indicate greater potency. It relates to Ki by the Cheng-Prusoff equation. Explore the full definition and applications on this page.

How does IC50 relate to binding affinity?

IC50 is closely connected to binding affinity and other Drug Discovery concepts. Understanding these relationships is essential for comprehensive knowledge in molecular biology and bioinformatics.

How does VigyanLLM use IC50 in its pipeline?

VigyanLLM's 24-step validated pipeline incorporates IC50 as part of its rigorous quality control framework. The platform automates checks related to IC50 to ensure primer design accuracy, specificity, and reliability for research and clinical applications.

VigyanLLM Application

VigyanLLM's validated pipeline addresses binding affinity and IC50 through automated computational checks. Explore how the platform handles IC50 across its 24-step framework:

Explore on VigyanLLM → Primer Design Tool → Primer Design Best Practices → Primer3 Alternative →